Electromed Inc Cash Flow Conversion Efficiency

Latest as of December 2025: 0.067x

Electromed Inc cash flow conversion efficiency. Based on the latest financial reports, Electromed Inc (ELMD) has a cash flow conversion efficiency ratio of 0.067x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.03 Million) by net assets ($45.44 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Electromed Inc (2008–2025)

Cash flow conversion efficiency of Electromed Inc from 2008 to 2025. This chart illustrates how Electromed Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ELMD stock price for real-time trading data and today's change.

Electromed Inc Cash Flow Conversion Ratio Explained

Electromed Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Electromed Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Electromed Inc ranked by their cash flow conversion efficiency. Also see Electromed Inc (ELMD) market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Suzhou Harmontronics Auto Tech Co Ltd
SHG:688022
-0.032x
Xinjiang Youhao Group Co Ltd
SHG:600778
0.268x
Nampak
JSE:NPK
0.429x
Hirequest Inc
NASDAQ:HQI
0.023x
GE Power India Limited
NSE:GEPIL
1.009x
Shenzhen Keybridge Communications Co Ltd
SHE:002316
0.035x
Nam Kim Steel JSC
VN:NKG
0.062x
Global Water Resources Inc
NASDAQ:GWRS
0.097x

Annual Cash Flow Conversion Efficiency for Electromed Inc (2008–2025)

The table below shows the annual cash flow conversion efficiency of Electromed Inc from 2008 to 2025. Review ELMD cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 $43.21 Million $11.39 Million 0.264x +29.54%
2024-06-30 $44.55 Million $9.07 Million 0.204x +483.04%
2023-06-30 $37.67 Million $1.31 Million 0.035x +273.91%
2022-06-30 $34.17 Million $-686.00K -0.020x -121.15%
2021-06-30 $32.42 Million $3.08 Million 0.095x -31.57%
2020-06-30 $30.25 Million $4.20 Million 0.139x +37.83%
2019-06-30 $25.73 Million $2.59 Million 0.101x -9.77%
2018-06-30 $21.90 Million $2.44 Million 0.112x +78.56%
2017-06-30 $19.07 Million $1.19 Million 0.062x -52.84%
2016-06-30 $16.36 Million $2.17 Million 0.132x -33.69%
2015-06-30 $13.92 Million $2.78 Million 0.200x +23.19%
2014-06-30 $12.72 Million $2.06 Million 0.162x +20.34%
2013-06-30 $13.93 Million $1.88 Million 0.135x +273.42%
2012-06-30 $15.08 Million $-1.17 Million -0.078x +19.25%
2011-06-30 $14.71 Million $-1.42 Million -0.096x -218.12%
2010-06-30 $7.46 Million $607.94K 0.081x +142.63%
2009-06-30 $6.06 Million $-1.16 Million -0.191x -417.55%
2008-06-30 $4.04 Million $243.16K 0.060x --

About Electromed Inc

NYSE MKT:ELMD USA Medical Devices
Market Cap
$316.28 Million
Market Cap Rank
#15955 Global
#3822 in USA
Share Price
$38.22
Change (1 day)
-0.93%
52-Week Range
$23.15 - $38.58
All Time High
$38.58
About

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as we… Read more